Skip to main content

Advertisement

Table 2 Effects of AqE on cardiac function in L-NAME induced hypertensive mice (mean ± SD, n = 10)

From: The protective effects of polysaccharide extract from Xin-Ji-Er-Kang formula on Ang II-induced HUVECs injury, L-NAME-induced hypertension and cardiovascular remodeling in mice

Group LVSP(mmHg) LVEDP(mmHg) +dp/dtmax(mmHg/s) -dp/dtmax(mmHg/s)
Control 89.25 ± 13.02 −0.31 ± 1.79 4616.92 ± 713.09 − 3855.15 ± 659.27
Model 114.5 ± 15.16** −1.15 ± 6.09 5487.19 ± 674.56* − 4767.96 ± 934.34*
L-NAME+AqE 116.76 ± 9.96 −0.09 ± 8.25 4777.74 ± 797.27 − 3502.52 ± 976.41##
L-NAME+XJEK 111.41 ± 15.36 −1.18 ± 5.13 4873.61 ± 1113.51 − 3849.29 ± 1039.70
L-NAME+Fosinopril 100.56 ± 21.72# 0.37 ± 5.32 4618.46 ± 339.42## − 3457.26 ± 736.12##
  1. LVSP left ventricular systolic pressure, LVEDP left ventricular end-diastolic pressure, +dp/dtmax maximal rate of left ventricular systolic pressure, −dp/dtmax maximal rate of left ventricular diastolic pressure. *P < 0.05, **P < 0.01 vs control; #P < 0.05, ##P < 0.01 vs model